Unique ID issued by UMIN | UMIN000024364 |
---|---|
Receipt number | R000026344 |
Scientific Title | A pilot study to plan a protocol for the clinical trial evaluating the efficacy of Rikkunshito for patients after total gastrectomy |
Date of disclosure of the study information | 2016/11/01 |
Last modified on | 2020/11/19 22:31:19 |
A pilot study to plan a protocol for the clinical trial evaluating the efficacy of Rikkunshito for patients after total gastrectomy
A pilot study to evaluate the efficacy of Rikkunshito for patients after total gastrectomy
A pilot study to plan a protocol for the clinical trial evaluating the efficacy of Rikkunshito for patients after total gastrectomy
A pilot study to evaluate the efficacy of Rikkunshito for patients after total gastrectomy
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
The aim of this study is to establish the most suitable protocol for a clinical trial to evaluate the effect of early administration of Rikkunshito on weight loss, decreased appetite and reduced quality of life after total gastrectomy in patients with gastric cancer.
Safety,Efficacy
Others
Others
Not applicable
Weight loss at three months after surgery
Medication compliance of Rikkunshito
Adverse events associated with Rikkunshito
Quality of life score
Plasma glucagon-like peptide-1
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Treatment
Medicine |
Oral administration of Rikkunshito 7.5g per day for 84 days from post operative day three.
No oral administration of Rikkunshito perioperatively.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Histological proven adenocarcinoma of stomach
2. cT1-T4a and no distant metastasis
3. R0 resection with total gastrectomy
4. Age 20-80 years
5. Eastern Cooperative Oncology Group performance status 0-1
6. Normal function of organ systems
7. Written informed consent
1. Synchronous or metachronous cancer
2. Reduced oral intake
3. Past gastrointestinal surgery
4. Preoperative chemotherapy
5. Administration of Rikkunshito ingredients before surgery
6. Unstable angina or myocardial infarction within six months
7. Pulmonary disease treated with continuous oxygen
8. Hemorrhagic tendency
9. Diabetes mellitus
10. Systemic treatment with corticosteroids
11. Pregnancy, breast-feeding, or contemplating pregnancy.
12. Mental disorder that affects informed consent or study protocol
10
1st name | Naohiro |
Middle name | |
Last name | Sata |
Jichi Medical University Hospital
Department of Surgery
329-0498
3311-1, Yakushiji, Shimotsuke city, Tochigi, 329-0498, Japan
0285-58-7371
sata@jichi.ac.jp
1st name | Yoshinori |
Middle name | |
Last name | Hosoya |
Jichi Medical University Hospital
Department of Surgery
329-0498
3311-1, Yakushiji, Shimotsuke city, Tochigi, 329-0498, Japan
0285-58-7371
hosoyo@jichi.ac.jp
Jichi Medical University
None
Self funding
Support Center for Clinical Investigation, Jichi Medical University
Yakushiji3311-1, Shimotsuke, Tochigi
0285-58-8933
nintei-rinri@jichi.ac.jp
NO
2016 | Year | 11 | Month | 01 | Day |
Published
12
Main results already published
2016 | Year | 03 | Month | 22 | Day |
2016 | Year | 03 | Month | 22 | Day |
2017 | Year | 04 | Month | 01 | Day |
2020 | Year | 10 | Month | 31 | Day |
2016 | Year | 10 | Month | 11 | Day |
2020 | Year | 11 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026344